Features

Menopause Matters April 2024

The ovarian transplant debate Ovarian tissue auto-transplantation is used when a young woman is facing genito-toxic therapy for cancer. The process of removing healthy ovarian tissue, cryopreserving the sample and re-implanting it at a later date has proven value in allowing fertility in patients... Members Login to Read more...

NOTICE OF GENERAL MEETING

AUSTRALASIAN MENOPAUSE SOCIETY LIMITED ACN 167 422 380 (“Company”) Notice of General Meeting Notice is hereby given that a General Meeting of the Company will be held at 1000 AEST on 18 May 2024 via Zoom Register in advance for this meeting: here Agenda No Item Action 1. Present and Welcome 1... Members Login to Read more...

eChanges April 2024

Inside this issue AMS News President's Editorial Menopause Matters Menopausal Hormone Therapy (MHT) patch shortages April 2024 Menopause Down Under, Sydney | recording now available for review IMS World Congress on Menopause in Melbourne 2024 News from Around the World Obesity and menopause: Is... Members Login to Read more...

Climacteric E-alert - Vol 27 Iss 2 April 2024

Issue Highlights for April 2024Volume 27, Number 2 Welcome to the April 2024 issue of Climacteric, my first as Editor-in-Chief. We have a varied edition covering a range of topics. I hope you enjoy reading this edition. Tim Hillard, Editor-in-Chief. Members Login to Read more...

Non-pharmacological Interventions for VMS - 11.00 PM AEST 16 April 2024

Moderator: Professor Peter Schnatz Speakers: Professor Myra Hunter: ‘Cognitive Behavioural Therapy (CBT)’ Professor Gary Elkins: ‘Hypnosis’ Date and Time: Apr 16, 2024 11:00 PM AEST As this webinar is late, it may not be convenient for you to attend. The recorded webinar will be available on the... Members Login to Read more...

eChanges March 2024

Inside this issue AMS News President's Editorial Testosterone use in women The Lancet series on Menopause Menopausal Hormone Therapy (MHT) discontinuation and shortages March 2024 Menopause Down Under, Sydney | Saturday 6 April 2024 IMS World Congress on Menopause in Melbourne 2024 News from... Members Login to Read more...

Lancet series on Menopause 2024

The Lancet has published a series on menopause which cautions against the ‘over medicalisation’ of menopause, and calls for an empowerment model. AMS agrees that we need to empower women to manage their menopause transition, their post-menopausal health and well-being, and indeed has been... Read more...

eChanges February 2024

Inside this issue AMS News President's Report Cognitive Decline Menopausal Hormone Therapy (MHT) discontinuation and shortages February 2024 AMS Webinar: Vasomotor symptom (VMS) management with non-hormonal options Menopause Down Under, Sydney | Saturday 6 April 2024 IMS World Congress on... Members Login to Read more...

eChanges January 2024

Inside this issue AMS News President's Report Updated AMS Information Sheet: Bleeding – perimenopausal, postmenopausal and breakthrough bleeding on MHT/HRT Menopausal Hormone Therapy (MHT) discontinuation and shortages January 2024 IMS World Congress on Menopause in Melbourne 2024 News from Around the... Members Login to Read more...

Sexually Transmitted Infections in Midlife Women

According to the Centers for Disease Control and Prevention (CDC), rates of sexually transmitted infections (STIs) are increasing in all age groups. And, contrary to the common assumption that older women are not sexually active or are in mutually monogamous relationships, a high proportion of... Members Login to Read more...

How do we best support women in the workplace as they transition through menopause?

By Dr Marita Long Women can experience a range of symptoms as they transition through the menopause years and some of these can have a significant impact on their attendance and performance in the workplace. This has given rise to considerable discussion and debate around how we can best support... Members Login to Read more...

eChanges December 2023

Inside this issue AMS News President's Report How do we best support women in the workplace as they transition through menopause? Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages Seasons Greetings IMS World Congress on Menopause in Melbourne 2024 News from Around the World... Members Login to Read more...

Neurodiverse Women and Menopause

By Dr Carmel Reynolds There has been a relatively recent increase in community awareness of neurodivergence in women, and this has had a significant flow on effect in the numbers of women presenting for assessment. I am sure that most practitioners working in primary care and mental health fields... Members Login to Read more...

eChanges November 2023

Inside this issue AMS News President's Report Neurodiverse Women and Menopause Senate Inquiry into issues relating to menopause and perimenopause Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages IMS - A Special Membership Offer for Members of the Australasian Menopause Society IMS... Members Login to Read more...

A Practitioner’s Toolkit for the Management of the Menopause

Developed by the Women’s Health Research Program in the Monash University School of Public Health and Preventive Medicine, 2023.The supporting notes for the Practitioner’s Toolkit for Managing Menopause are published, with free access, in Climacteric, the journal of the International Menopause... Read more...

Management of menopause

By Dr Karen Magraith and Dr Christina Jang: Menopausal hormone therapy is the most effective treatment for menopausal symptoms and, for most women, the benefits of symptom control outweigh the potential harms of therapy. The article is available free online from the Australian Prescriber, Issue 3... Read more...

IMS White Paper – Reproductive milestones across the lifespan and cardiovascular disease risk in women

Cardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in... Read more...

eChanges September 2023

Inside this issue AMS News President's Report Updated AMS Information Sheet: Tibolone as menopausal hormone therapy 26th Annual Australasian Menopause Society Congress Synopsis New AMS Board Director: Dr Amie Hanlon AMS Congress Award and Prize Winners AMS Scholarship – Ms Celine Camon Menopause... Members Login to Read more...

Menopause Essentials Update 2023

Saturday 4 November - 12.00-4.30pm Join us for lunch followed by an update on the essentials of menopause management. This workshop is aimed at GPs, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review of the current issues that face them in the... Read more...

FRAXplus®: Refining risk prediction

Accurate assessment of fracture risk is essential for optimal diagnosis and management of osteoporosis.The FRAX® fracture risk assessment tool has substantially improved the identification of people at high risk of fracture since its launch in 2008. To date, 86 FRAX models have been made available... Members Login to Read more...